Search Results

Displaying Results 3251-3275 of 20586 "'R'"

Jul 22, 2026, 11:54 ET Cool Air Salute to Assist Military Community Launches Across California

Car Care Council and funded entirely by unclaimed deposits on cans of R-134a refrigerant, in coordination with the California Air Resources Board. As of this summer, the program has infused $8 million directly into the local

More news about: Cool Air Rebate Program


Jul 22, 2026, 10:55 ET Yili rassemble des talents internationaux lors du 2026 Global Elite Summit, célébrant la diversité et une vision commune

laitière, les collaborateurs en visite sur site ont pu constater comment les technologies numériques de pointe, la fabrication intelligente et une R&D rigoureuse garantissent le respect des normes de qualité des produits Yili. Pour les collègues issus de marchés différents, cet engagement commun en

More news about: Yili Group


Jul 22, 2026, 10:31 ET CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight

witnessing rapid expansion, driven by the transition from conventional chemo-immunotherapy to advanced cell-based treatment modalities. Strong efficacy in R/R disease, growing adoption in 2L and beyond, and the launch of emerging therapies such as Zamtocabtagene autoleucel (Miltenyi Biomedicine), Rapcabtagene

More news about: DelveInsight Business Research, LLP


Jul 22, 2026, 10:30 ET AI in Drug Discovery Market worth $17.56 billion by 2031 - Exclusive Report by MarketsandMarkets™

greater precision. The increasing availability of multi-omics datasets, expanding investments in precision medicine, and rising demand to improve R&D productivity are creating new revenue opportunities for AI platform providers, software developers, and life sciences technology companies. As pharmaceutical

More news about: MarketsandMarkets


Jul 22, 2026, 10:00 ET Prevent Blindness Introduces New Resources and Advances National and State Advocacy Efforts to Save Children's Vision as Part of August's Children's Eye Health and Safety Month

Congressional Vision Caucus co-chairs Representatives Gus Bilirakis (R-FL) and Marc A. Veasey (D-TX). This bipartisan legislation seeks to establish the first national program specifically aimed at improving children's vision

More news about: Prevent Blindness


Jul 22, 2026, 09:32 ET CoAspire Awarded $70m Department of the Navy CHAOS Cruise Missile Agreement

Ground-Launched. CoAspire's' RAACM-ER Ground-Launched—adapted for the specific requirements of CHAOS—is comparable to the RAACM‑ER GHOST variant used in the OUSW R&E and U.S. Army PAE Fires-funded Low-Cost Containerized Munition (LCCM) program."CoAspire is thrilled to support the U.S. Navy with this much-needed,

More news about: CoAspire


Jul 22, 2026, 09:30 ET Challenging Patriarchy in Christianity: New Book Explores Gender, Scripture, and the Gospel

theologyFORT WAYNE, Ind., July 22, 2026 /PRNewswire/ -- In author Pauline R. Beer's eyes, female oppression is visibly embedded in the Bible but generally ignored or misrepresented by preachers and theologians. When scripture

More news about: LifeRich Publishing


Jul 22, 2026, 09:19 ET Origin Merchant Partners Combines with Boston and New York-based Consensus to Build North America's Leading Independent Consumer & Retail M&A Practice

existing consumer practice and broaden its U.S. coverage. Consensus has advised on transactions with iconic brands such as Nine West, Timex Group, Toys 'R' Us, MODA Operandi, Lenox, Kohl's, and Jewelry Television. Most recently, Consensus advised L Catterton and other sellers in the sale of Everlane to global

More news about: Origin Merchant Partners


Jul 22, 2026, 09:00 ET Formation Bio Appoints Michael Ehlers as Chief Scientific Officer and Head of R&D

the appointment of Michael D. Ehlers, MD, PhD, as Chief Scientific Officer (CSO) and Head of Research & Development (R&D). Ehlers will provide end-to-end scientific and R&D leadership across Formation Bio. He will oversee portfolio strategy and advancement, from translational sciences through

More news about: Formation Bio


Jul 22, 2026, 09:00 ET Targeting the $100 Billion Market: Insilico Medicine Nominates AI-driven Novel PCC ISM9528 for Pain Management

nominated since 2021, ISM9528 further validates the capabilities of Insilico's proprietary Pharma.AI platform to consistently accelerate and empower drug R&D innovation.CAMBRIDGE, Mass., July 22, 2026 /PRNewswire/ -- Despite

More news about: Insilico Medicine


Jul 22, 2026, 09:00 ET Kong Opens New Offices in Paris and Milan, Driven by EMEA Customer Growth

The Milan office will serve as a growing engineering hub to support R&D, product innovation, and customer success across the region. The new office marks a return to the city where Kong's co-founders, Augusto Marietti and

More news about: Kong Inc.


Jul 22, 2026, 09:00 ET ACMI ANNOUNCES NEW TENANTS AND MAJOR EXPANSION OF ITS NATIONAL SECURITY INDUSTRIAL HUB TO MORE THAN 1,500 ACRES

as a manufacturing node where multiple advanced technology, aerospace, and logistics companies will rapidly transition new hardware from advanced R&D to scaled production.By lowering startup and expansion costs, reducing capital risk, and shortening the path from design to production, ACMI's

More news about: American Center for Manufacturing and Innovation


Jul 22, 2026, 09:00 ET First Community Corporation Announces Leadership Transition, Second Quarter Results and Increased Cash Dividend

he moves into this next season."  With Mr. Nissen's retirement, the CEO and President role will be split and effective January 1, 2027, Vaughan R. Dozier will become Chief Executive Officer of First Community Bank and Joseph A. "Drew" Painter will become President of the bank.  With their new roles,

More news about: First Community Corporation


Jul 22, 2026, 08:45 ET The Protein Paradox: New Survey Finds Consumers Are Calling Time-Out on Protein Gimmicks

protein continues to dominate food trends, nearly every category is trying to claim a seat at the table," said Holly LaVallie, SVP of Marketing and R&D at Link Snacks. "But not all protein is created equal. We believe real meat protein remains the gold standard, an essential part of our diets, complete

More news about: Link Snacks, Inc.


Jul 22, 2026, 08:45 ET New Zealand's Gold and Antimony Renaissance Is Attracting Serious Capital. This Dual-Project Explorer Just Made Its Board Match Its Ambitions.

Companies mentioned: RUA GOLD Inc. (TSX: RUA) (NZX: RGI) (OTCQX: NZAUF) (FSE: X9R), OceanaGold Corporation (TSX: OGC) (NYSE: OGC), Siren Gold Limited (ASX: SNG), Perpetua Resources Corp. (NASDAQ: PPTA) (TSX: PPTA), Santana Minerals

More news about: USA News Group


Jul 22, 2026, 08:36 ET The Failure to Fund Social Security Could Cost Average American Couple Retiring in Eight Years More Than $160,000 in Lost Benefits and a High-Income Couple $500,000

today."Any reduction in guaranteed income, regardless of the source, will put significant pressure on retirees' budgets and financial security," said Michael R. Daley, Director of Research and Marketing, HealthView Services. "As the data show, the impact of the loss of even a portion of the lifetime income that

More news about: HealthView Services


Jul 22, 2026, 08:30 ET Ribo Discloses Positive Data from Vortosiran Phase 2a Trial - World's First Clinical Data on siRNA-Mediated FXI Inhibition Following Multiple Dosing in Patients with Coronary Artery Disease

Life Science Co. Ltd. (Ribo, 06938.HK) is an innovative clinical stage R&D company devoted to the development of nucleic acid drugs and related products based on the RNA interference (RNAi) technology. With its innovative R&D capabilities with vertically integrated technological platforms, Ribo

More news about: Suzhou Ribo Life Science Co., Ltd.


Jul 22, 2026, 08:22 ET Ribo Discloses Positive Data from Vortosiran Phase 2a Trial - World's First Clinical Data on siRNA-Mediated FXI Inhibition Following Multiple Dosing in Patients with Coronary Artery Disease

Life Science Co. Ltd. (Ribo, 06938.HK) is an innovative clinical stage R&D company devoted to the development of nucleic acid drugs and related products based on the RNA interference (RNAi) technology. With its innovative R&D capabilities with vertically integrated technological platforms, Ribo

More news about: Suzhou Ribo Life Science Co., Ltd.


Jul 22, 2026, 08:00 ET Republic of Honduras Announces Expiration of Tender Offer

Rule 144A Common Code: 155344334Regulation S CUSIP: P5178R AC2Regulation S ISIN: USP5178RAC27Regulation

More news about: Republic of Honduras


Jul 22, 2026, 08:00 ET Ottobock Releases One of the First-Ever Community-Built Image Libraries to Improve Representation of People with Limb Loss and Limb Differences in AI

the largest international patient care network with around 420 patient care clinics. Ottobock is shaping the future of human bionics with a strong R&D ratio in the products and components business and over 2,600 patents and patent applications. Ottobock's mission of improving freedom of movement,

More news about: Ottobock


Jul 22, 2026, 08:00 ET Stearns & Foster Introduces 2026 Luxury Mattress Collections With Advanced Cooling, Patented Support and Handcrafted Design

deliver mattresses capable of giving people restorative sleep, year after year. No other luxury mattress brand can offer the same trusted combination of R&D, comfort and quality." Key Features of the 2026 Stearns & Foster Luxury Innerspring and Hybrid Mattress Collections Advanced

More news about: Tempur Sealy International, Inc.


Jul 22, 2026, 07:40 ET TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference

product candidates, TuHURA is developing TBS-2025, a VISTA inhibiting mAb moving into dose escalation/optimization Phase 1b trial in mutNPM1 r/r AML, a molecularly defined subgroup representing approximately 35% of patients with AML. TuHURA is also leveraging its Delta Opioid Receptor technology

More news about: TuHURA Biosciences, Inc.


Jul 22, 2026, 07:37 ET Exposure to Weed Killer During Pregnancy May Increase Risk of Preterm Birth

through which glyphosate exposure may affect fetal development and birth.Funding for the study was provided by National Institutes of Health grants R01ES032214 and ES036249.Dr. Trasande has received travel reimbursement support from the Endocrine Society, the World Health Organization, the United

More news about: NYU Grossman School of Medicine and NYU Langone Health


Jul 22, 2026, 07:30 ET BTQ Technologies' QPerfect Subsidiary and the University of Strasbourg Partner to Support France's First Public Neutral-Atom Quantum Computing Platform

QPerfect joins the aQCess team to build a hardware-accurate digital twin of the processor with MIMIQ™ as a tool to accelerate quantum software R&DVANCOUVER, BC, July 22, 2026 /PRNewswire/ --

More news about: BTQ Technologies Corp.


Jul 22, 2026, 07:04 ET Citadel Securities otwiera biuro w Amsterdamie

instytucjonalnym i europejskim rynkom kapitałowym.MIAMI, 22 lipca 2026 r. /PRNewswire/ -- Citadel Securities, bazujący na technologiach globalny animator rynku nowej generacji, ogłosił dzisiaj otwarcie nowego biura w Amsterdamie,

More news about: Citadel Securities


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.